Amneal Pharmaceuticals Inc
(AMRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2008 | 12-2007 | 12-2006 | 09-2004 | 06-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 460 | 125,410 | -12,044 | 6,272 | 9,620 |
| Depreciation Amortization | 14,729 | 67,923 | 33,734 | 3,263 | 2,082 |
| Income taxes - deferred | 163 | 16,427 | N/A | N/A | N/A |
| Accounts receivable | -36,245 | 9,868 | -31,393 | -9,845 | -13,455 |
| Other Working Capital | -39,259 | 18,845 | -24,093 | -25,223 | -20,985 |
| Other Operating Activity | 56,234 | -119,459 | 28,036 | 7,432 | 11,042 |
| Operating Cash Flow | $-3,918 | $119,014 | $-5,760 | $-18,101 | $-11,696 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -9,404 | -79,452 | -22,228 | -44,821 | -45,244 |
| PPE Investments | -4,241 | -18,836 | -21,475 | -8,692 | -6,269 |
| Investing Cash Flow | $-13,645 | $-98,288 | $-43,703 | $-53,513 | $-51,513 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 92,290 | 92,358 |
| Debt Repayment | -66 | -253 | -108 | -1,656 | -1,501 |
| Common Stock Issued | 154 | 113 | 93 | 3,869 | 3,771 |
| Other Financing Activity | 0 | 10,477 | 0 | 6,388 | 6,388 |
| Financing Cash Flow | $88 | $10,337 | $-15 | $100,891 | $101,016 |
| Beginning Cash Position | 37,462 | 6,399 | 55,877 | 15,505 | 15,505 |
| End Cash Position | 19,987 | 37,462 | 6,399 | 44,782 | 53,312 |
| Net Cash Flow | $-17,475 | $31,063 | $-49,478 | $29,277 | $37,807 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,918 | 119,014 | -5,760 | -18,101 | -11,696 |
| Capital Expenditure | -4,241 | -18,836 | -21,475 | -8,692 | -6,269 |
| Free Cash Flow | -8,159 | 100,178 | -27,235 | -26,793 | -17,965 |